Summary by Moomoo AI
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. repurchased a total of 3,359,666 shares of A-shares ordinary shares through the Shanghai Stock Exchange from 8 to 26 March 2024, representing approximately 0.13% of the company's issued shares. The Company's share repurchase price ranges from RMB 47.5 to RMB 57.32, and on March 26, 2024 it repurchased 422,000 shares for a total amount of RMB 20,045,895. In addition, on the same day, the company issued 29,747 shares of A-share ordinary shares under the 2019 A-share incentive plan. Following the share repurchase and exercise of options, the total number of shares issued by the Company as of March 26, 2024 was 2,546,239,690 shares. Pursuant to the Listing Rules of the Hong Kong Stock Exchange Limited, the Company has completed the relevant disclosure requirements and confirmed that all transactions have been approved by the Board of Directors and comply with the relevant legal requirements.